Researchers have developed a novel class of engineered cytokine agonists called Trikines to overcome the limitations of natural immune signaling. By compelling the assembly of three-chain receptor complexes, these molecules allow scientists to customize cellular responses by activating specific combinations of STAT transcription factors. This "mix-and-match" strategy creates bespoke signaling outp...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动